External-beam radiation therapy (EBRT) use and safety with Radium-223 dichloride (Ra) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the ALSYMPCA trial

Authors :: Stroelin, P.
O'Sullivan, J.
Sartor, O.
Parker, C.
Hoskin, P.
Widmark, Anders
Mellado, B.
Helle, S.
Aksnes, A.
Garcia-Vargas, J.
Nilsson, S.
Stroelin, P.
O'Sullivan, J.
Sartor, O.
Parker, C.
Hoskin, P.
Widmark, Anders
Mellado, B.
Helle, S.
Aksnes, A.
Garcia-Vargas, J.
Nilsson, S.
Publication Year :: 2015
Abstract: Supplement: 5 Meeting Abstract: P264

Tools